Showing results (721-730 of 14,088) with videos related to

Sort By:
Pageof 1,409
Gynecologic Oncology|January 2, 2016
Wilms tumor protein 1 (WT1)-- not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinomaEliane Tabea Taube, Carsten Denkert, Jalid Sehouli, et al.
Gynecologic Oncology|October 7, 2015
The effect of lifestyle interventions on the quality of life of gynaecological cancer survivors: A systematic review and meta-analysisAnke Smits, Alberto Lopes, Nagindra Das, et al.
Gynecologic Oncology|October 13, 2015
De-escalation of the cumulative central radiation dose according to the tumor response can reduce rectal toxicity without compromising the treatment outcome in patients with uterine cervical cancerKyung Hwan Kim, Sunghoon Kim, Gwi Eon Kim, et al.
Gynecologic Oncology|July 5, 2014
Interferon regulatory factor 1 is an independent predictor of platinum resistance and survival in high-grade serous ovarian carcinomaSamantha Cohen, Rebecca Mosig, Erin Moshier, et al.
Gynecologic Oncology|September 13, 2015
Robotic versus laparoscopic versus open surgery in morbidly obese endometrial cancer patients - a comparative analysis of total charges and complication ratesJohn K Chan, Austin B Gardner, Katie Taylor, et al.
Gynecologic Oncology|September 15, 2015
Assessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic massElizabeth Lokich, Marguerite Palisoul, Nicole Romano, et al.
Gynecologic Oncology|March 1, 1989
Malignant melanoma of the uterine cervix: case report and review of the literatureN Mordel, S Mor-Yosef, N Ben-Baruch, et al.
Gynecologic Oncology|September 1, 1989
Human papillomavirus and epithelial ovarian neoplasiaJ F Leake, J D Woodruff, C Searle, et al.
Gynecologic Oncology|September 1, 1989
Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinomaW J Hoskins, S C Rubin, E Dulaney, et al.
Gynecologic Oncology|November 10, 2015
Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancerLinda E Kelemen, Graham W Warren, Jennifer M Koziak, et al.
Pageof 1,409